Airdate: Tuesday, November 26, 2024 Season: 3 Episode: 7
Guest: Bas Trietsch
In this interview, Drs. Bas Trietsch from MIMETAS and Jenna Moccia from STEMCELL Technologies explore the use of stem cell-based models in drug discovery. They discuss how regulatory milestones underscore the growing acceptance of these models, prompting scientists to seek out clinically predictive tools such as organoids and organ-on-a-chip systems.
You can learn more about the importance of human-based 3D model systems, their impact on drug discovery, and the future outlook of this technology in the full interview with Jenna and Bas here.
Similar Podcasts
#ExpertAnswers: Jack Vanden Heuvel on Prediction Drug-Drug Interactions Early
Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses methodologies for predicting drug-drug interactions using in vitro assays and gene expression studies.
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments
Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.
#ExpertAnswers: Travis Hardcastle and Seth Hanson on Using CRISPR and iPSCs for Neuroscience Research
Travis Hardcastle and Seth Hanson answer questions from a webinar where they discuss innovative applications of CRISPR and iPSCs in disease modeling and drug discovery.